GB9808894D0 - Novel compound - Google Patents
Novel compoundInfo
- Publication number
- GB9808894D0 GB9808894D0 GBGB9808894.1A GB9808894A GB9808894D0 GB 9808894 D0 GB9808894 D0 GB 9808894D0 GB 9808894 A GB9808894 A GB 9808894A GB 9808894 D0 GB9808894 D0 GB 9808894D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compound
- novel
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9808894.1A GB9808894D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
BR9909878-4A BR9909878A (en) | 1998-04-25 | 1999-04-23 | 10-paroxetine camphosulfonate for treatment of central nervous system disorders |
APAP/P/2000/001958A AP2000001958A0 (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfornate for treatment of CNS disorders. |
AU36186/99A AU3618699A (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for treatment of cns disorders |
PCT/GB1999/001246 WO1999055699A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for treatment of cns disorders |
CA002329913A CA2329913A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for treatment of cns disorders |
IL13901899A IL139018A0 (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for treatment of cns disorders |
KR1020007011750A KR20010042929A (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-Camphorsulfonate For Treatment Of CNS Disorders |
HU0102298A HUP0102298A2 (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for treatment of cns disorders and process for its preparation |
PL99343596A PL343596A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for treatment of cns disorders |
TR2000/03083T TR200003083T2 (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for the treatment of CNS diseases. |
EA200001105A EA200001105A1 (en) | 1998-04-25 | 1999-04-23 | 10-Camforsulfonat Paroxetine for the treatment of CNS disorders |
CN99807798A CN1306530A (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for treament of CNS disorders |
SK1590-2000A SK15902000A3 (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for treatment of cns disorders |
EP99918153A EP1076659A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for treatment of cns disorders |
JP2000545859A JP2002513020A (en) | 1998-04-25 | 1999-04-23 | Paroxetine 10-camphorsulfonate for the treatment of CNS diseases |
NO20005351A NO20005351L (en) | 1998-04-25 | 2000-10-24 | Paroxetine 10-camphor sulfonate for the treatment of CNS disorders |
BG104973A BG104973A (en) | 1998-04-25 | 2000-11-21 | Paroxetine 10-camphorsulfonate for treatmnent of cns disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9808894.1A GB9808894D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9808894D0 true GB9808894D0 (en) | 1998-06-24 |
Family
ID=10831007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9808894.1A Ceased GB9808894D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1076659A1 (en) |
JP (1) | JP2002513020A (en) |
KR (1) | KR20010042929A (en) |
CN (1) | CN1306530A (en) |
AP (1) | AP2000001958A0 (en) |
AU (1) | AU3618699A (en) |
BG (1) | BG104973A (en) |
BR (1) | BR9909878A (en) |
CA (1) | CA2329913A1 (en) |
EA (1) | EA200001105A1 (en) |
GB (1) | GB9808894D0 (en) |
HU (1) | HUP0102298A2 (en) |
IL (1) | IL139018A0 (en) |
NO (1) | NO20005351L (en) |
PL (1) | PL343596A1 (en) |
SK (1) | SK15902000A3 (en) |
TR (1) | TR200003083T2 (en) |
WO (1) | WO1999055699A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100672184B1 (en) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | Paroxetine cholate or cholic acid derivative salts |
CN104402708A (en) * | 2014-12-07 | 2015-03-11 | 河南领先科技药业有限公司 | Production method for sodium camphorate |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
ES2058061T3 (en) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT. |
HU221921B1 (en) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them |
-
1998
- 1998-04-25 GB GBGB9808894.1A patent/GB9808894D0/en not_active Ceased
-
1999
- 1999-04-23 JP JP2000545859A patent/JP2002513020A/en active Pending
- 1999-04-23 AU AU36186/99A patent/AU3618699A/en not_active Abandoned
- 1999-04-23 AP APAP/P/2000/001958A patent/AP2000001958A0/en unknown
- 1999-04-23 CN CN99807798A patent/CN1306530A/en active Pending
- 1999-04-23 CA CA002329913A patent/CA2329913A1/en not_active Abandoned
- 1999-04-23 EP EP99918153A patent/EP1076659A1/en not_active Withdrawn
- 1999-04-23 IL IL13901899A patent/IL139018A0/en unknown
- 1999-04-23 SK SK1590-2000A patent/SK15902000A3/en unknown
- 1999-04-23 HU HU0102298A patent/HUP0102298A2/en unknown
- 1999-04-23 KR KR1020007011750A patent/KR20010042929A/en not_active Application Discontinuation
- 1999-04-23 BR BR9909878-4A patent/BR9909878A/en not_active Application Discontinuation
- 1999-04-23 TR TR2000/03083T patent/TR200003083T2/en unknown
- 1999-04-23 EA EA200001105A patent/EA200001105A1/en unknown
- 1999-04-23 PL PL99343596A patent/PL343596A1/en not_active Application Discontinuation
- 1999-04-23 WO PCT/GB1999/001246 patent/WO1999055699A1/en not_active Application Discontinuation
-
2000
- 2000-10-24 NO NO20005351A patent/NO20005351L/en not_active Application Discontinuation
- 2000-11-21 BG BG104973A patent/BG104973A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR9909878A (en) | 2000-12-26 |
WO1999055699A1 (en) | 1999-11-04 |
PL343596A1 (en) | 2001-08-27 |
EA200001105A1 (en) | 2001-04-23 |
SK15902000A3 (en) | 2001-05-10 |
BG104973A (en) | 2001-09-28 |
AP2000001958A0 (en) | 2000-12-31 |
HUP0102298A2 (en) | 2002-05-29 |
CA2329913A1 (en) | 1999-11-04 |
AU3618699A (en) | 1999-11-16 |
EP1076659A1 (en) | 2001-02-21 |
NO20005351D0 (en) | 2000-10-24 |
TR200003083T2 (en) | 2001-02-21 |
NO20005351L (en) | 2000-10-24 |
KR20010042929A (en) | 2001-05-25 |
JP2002513020A (en) | 2002-05-08 |
IL139018A0 (en) | 2001-11-25 |
CN1306530A (en) | 2001-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9801392D0 (en) | Novel compounds | |
GB0216752D0 (en) | Novel compound | |
GB9805348D0 (en) | Compound | |
GB9827431D0 (en) | Novel compound | |
GB9808268D0 (en) | Compound | |
GB9808896D0 (en) | Novel compound | |
GB9808894D0 (en) | Novel compound | |
GB9823175D0 (en) | Compound | |
GB9817310D0 (en) | Novel compound | |
GB9817323D0 (en) | Novel compound | |
GB9817337D0 (en) | Novel compound | |
GB9817338D0 (en) | Novel compound | |
GB9820404D0 (en) | Novel compound | |
GB9817321D0 (en) | Novel compound | |
GB9817307D0 (en) | Novel compound | |
GB9821732D0 (en) | Novel compound | |
GB9823856D0 (en) | Novel compound | |
GB9826172D0 (en) | Novel compound | |
GB9827277D0 (en) | Novel compound | |
GB9815871D0 (en) | Novel compound | |
GB9800324D0 (en) | Novel compounds | |
GB9802638D0 (en) | Novel compounds | |
GB9800337D0 (en) | Novel compounds | |
GB9802659D0 (en) | Novel compounds | |
GB9801630D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |